Similar results were obtained by Ochi et al., who showed that intracellular production of IL-13 in TCD4+ lymphocytes and TCD8+ lymphocytes of peripheral blood of patients with multiple sclerosis (MS) was significantly higher during MS remission than in healthy controls [37]. Here, IL13 is linked to myeloid sarcoma.